[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Jetema Co., Ltd.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":13,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100613377","study-of-jtm104-injection-vs-juvederm-in-treating-moderate-to-severe-nasolabial-folds-100613377",false,"NCT07265791","Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds","Multicenter, Randomized, Subject & Independent Evaluator-blind, Matched Pairs, Active-controlled, Non-inferiority, Pivotal Study to Evaluate the Efficacy and Safety of Injection With JTM104 as Compared to Juvederm® ULTRA PLUS XC in Temporary Correction of Moderate to Severe Nasolabial Folds","Inclusion Criteria:\n\n* Adults aged 19 to 75 years\n* Voluntarily provided written informed consent\n* Moderate to severe symmetrical nasolabial folds (WSRS score 3 or 4 on both sides)\n* Agree to discontinue other facial dermatologic treatments (e.g., fillers, botulinum toxin, laser) during the study\n* Able to understand instructions and comply with study procedures\n\nExclusion Criteria:\n\n* Untreated scars or facial skin infections\u002Fdiseases affecting the mid\u002Flower face within the past year\n* History of severe allergy or hypersensitivity to device components\n* Facial invasive procedures within the past 6 months (including surgery, laser, botulinum toxin)\n* Use of certain medications (anticoagulants, immunosuppressants, steroids) within specified washout periods\n* Participation in other interventional clinical trials within 4 weeks before screening or during study\n* Non-compliance with contraception requirements or pregnancy\u002Flactation during study\n* Deemed unsuitable by investigator for any other reason","ALL","19 Years","75 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA",[26],"Nasolabial Folds, Wrinkles","NOT_YET_RECRUITING","2025-11-24",{"date":30,"type":31},"2025-12-05","ACTUAL",{"date":33,"type":21},"2026-01-03",{"date":35,"type":21},"2027-01-31",{"name":37,"class":38},"Jetema Co., Ltd.","INDUSTRY",""]